Boule Diagnostics CEO Torben Nielsen Resigns After Restructuring Initiatives
Torben Nielsen is resigning as President and CEO of Boule Diagnostics, a role he began in April 2024. Nielsen led a restructuring that cut costs, stopped in-house hematology instrument development, shifted to a partner-based portfolio, and altered financial reporting to segment the company into Diagnostics and OEM Clinical Diagnostic Solutions.
Key takeaways
- Torben Nielsen will resign as President and CEO of Boule Diagnostics, a position he has held since April 2024
- During his tenure, Mr
- Nielsen spearheaded a significant restructuring initiative designed to reduce the company's cost base and enhance its long-term strategic positioning
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.